{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:50:57Z","timestamp":1792183857692,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jpeds.2021.12.035","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T01:16:43Z","timestamp":1640222203000},"page":"173-180.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Anakinra Treatment in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysms: A Phase I\/IIa Trial"],"prefix":"10.1016","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8263-8272","authenticated-orcid":false,"given":"Jincheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8408-1247","authenticated-orcid":false,"given":"Sonia","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund V.","family":"Capparelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brookie M.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7394-2862","authenticated-orcid":false,"given":"Mary Beth","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane W.","family":"Newburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4840-8182","authenticated-orcid":false,"given":"Alessandra","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth F.","family":"Printz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6860-6963","authenticated-orcid":false,"given":"Emelia","family":"Bainto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6953-3257","authenticated-orcid":false,"given":"Elizabeth","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Pancheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana H.","family":"Tremoulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2021.12.035_bib1","first-page":"245","article-title":"Pathological study of Kawasaki disease (MCLS), with special reference to sequelae","volume":"32","author":"Tanaka","year":"1979","journal-title":"Jpn J Med Sci Biol"},{"key":"10.1016\/j.jpeds.2021.12.035_bib2","first-page":"429","article-title":"[Histopathological studies of endomyocardial biopsy on the children with Kawasaki disease]","volume":"37","author":"Yonesaka","year":"1989","journal-title":"Kokyu To Junkan"},{"key":"10.1016\/j.jpeds.2021.12.035_bib3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jpeds.2018.07.090","article-title":"Kawasaki disease outcomes and response to therapy in a multiethnic community: a 10-year experience","volume":"203","author":"Skochko","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2021.12.035_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpeds.2017.03.025","article-title":"High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease","volume":"185","author":"Salgado","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2021.12.035_bib5","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.4049\/jimmunol.0901395","article-title":"Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease","volume":"183","author":"Schulte","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jpeds.2021.12.035_bib6","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/art.1780280609","article-title":"Coronary arteritis in mice following the systemic injection of group B Lactobacillus casei cell walls in aqueous suspension","volume":"28","author":"Lehman","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpeds.2021.12.035_bib7","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/ATVBAHA.115.306475","article-title":"IL-1 Signaling Is critically required in stromal cells in Kawasaki disease vasculitis mouse model: role of both IL-1\u03b1 and IL-1\u03b2","volume":"35","author":"Lee","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jpeds.2021.12.035_bib8","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.111.072769","article-title":"Interleukin-1\u03b2 is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease","volume":"125","author":"Lee","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2021.12.035_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/cei.13401","article-title":"IL-1-dependent electrophysiological changes and cardiac neural remodeling in a mouse model of Kawasaki disease vasculitis","volume":"199","author":"Abe","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jpeds.2021.12.035_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/cei.13314","article-title":"IL-1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis","volume":"198","author":"Gorelik","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jpeds.2021.12.035_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s13073-014-0102-6","article-title":"Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease","volume":"6","author":"Hoang","year":"2014","journal-title":"Genome Med"},{"key":"10.1016\/j.jpeds.2021.12.035_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fped.2020.00195","article-title":"Resolution of giant coronary aneurisms in a child with refractory Kawasaki disease treated with anakinra","volume":"8","author":"Gambacorta","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jpeds.2021.12.035_bib13","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1097\/RHU.0000000000000814","article-title":"Severe late-onset Kawasaki disease successfully treated with anakinra","volume":"26","author":"Blonz","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jpeds.2021.12.035_bib14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40272-020-00421-3","article-title":"Anakinra for treatment-resistant Kawasaki disease: evidence from a literature review","volume":"22","author":"Ferrara","year":"2020","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jpeds.2021.12.035_bib15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1017\/S1047951117002864","article-title":"Usefulness and safety of anakinra in refractory Kawasaki disease complicated by coronary artery aneurysm","volume":"28","author":"Guillaume","year":"2018","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jpeds.2021.12.035_bib16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.autrev.2018.01.024","article-title":"The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: a retrospective cases series","volume":"17","author":"Kone-Paut","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jpeds.2021.12.035_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12887-017-0852-6","article-title":"A child with resistant Kawasaki disease successfully treated with anakinra: a case report","volume":"17","author":"S\u00e1nchez-Manubens","year":"2017","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jpeds.2021.12.035_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1546-0096-12-26","article-title":"High-dose anakinra for treatment of severe neonatal Kawasaki disease: a case report","volume":"12","author":"Shafferman","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jpeds.2021.12.035_bib19","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1097\/INF.0000000000002810","article-title":"Anakinra and etanercept combination treatment in a child with severe, nonresponsive Kawasaki disease","volume":"39","author":"Walser","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2021.12.035_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.41481","article-title":"Phase II open-label study of anakinra in intravenous immunoglobulin-resistant Kawasaki disease","volume":"73","author":"Kon\u00e9-Paut","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jpeds.2021.12.035_bib21","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","article-title":"Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group","volume":"25","author":"Opal","year":"1997","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jpeds.2021.12.035_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cct.2016.04.002","article-title":"Rationale and study design for a phase I\/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial)","volume":"48","author":"Tremoulet","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jpeds.2021.12.035_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.echo.2010.10.004","article-title":"New equations and a critical appraisal of coronary artery z-scores in healthy children","volume":"24","author":"Dallaire","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"issue":"12 Suppl","key":"10.1016\/j.jpeds.2021.12.035_bib24","doi-asserted-by":"crossref","first-page":"S460","DOI":"10.1097\/01.CCM.0000185500.11080.91","article-title":"Interleukin-1beta","volume":"33","author":"Dinarello","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jpeds.2021.12.035_bib25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/eji.201747139","article-title":"Pediatric tolerogenic DCs expressing CD4 and immunoglobulin-like transcript receptor (ILT)-4 secrete IL-10 in response to Fc and adenosine","volume":"48","author":"Franco","year":"2018","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jpeds.2021.12.035_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/cei.12182","article-title":"Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin","volume":"174","author":"Burns","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jpeds.2021.12.035_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/cei.13506","article-title":"Characterization of circulating immune cells in acute Kawasaki disease suggests exposure to different antigens","volume":"202","author":"Burns","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jpeds.2021.12.035_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/2050-6511-14-40","article-title":"Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes","volume":"14","author":"Urien","year":"2013","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jpeds.2021.12.035_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/cts.12622","article-title":"Pharmacokinetics of anakinra in subjects of heavier vs. lighter body weights","volume":"12","author":"Yang","year":"2019","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jpeds.2021.12.035_bib30","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/art.41454","article-title":"American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1","volume":"72","author":"Henderson","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jpeds.2021.12.035_bib31","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1172\/JCI141113","article-title":"Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children","volume":"130","author":"Lee","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpeds.2021.12.035_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jpeds.2021.06.002","article-title":"Multisystem inflammatory syndrome of children: subphenotypes, risk factors, biomarkers, cytokine profiles, and viral sequencing","volume":"237","author":"DeBiasi","year":"2021","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2021.12.035_bib33","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347621012427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347621012427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:11:23Z","timestamp":1758359483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347621012427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":33,"alternative-id":["S0022347621012427"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2021.12.035","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anakinra Treatment in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysms: A Phase I\/IIa Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2021.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}